SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-19-010281
Filing Date
2019-08-07
Accepted
2019-08-07 16:04:18
Documents
2
Period of Report
2019-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aeri-2q19earningsrelease.htm 8-K 40310
2 EXHIBIT 99.1 aeri-2q19earningsreleaseex.htm EX-99.1 237471
  Complete submission text file 0001628280-19-010281.txt   278965
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36152 | Film No.: 191005427
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1